These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33850265)

  • 61. Tid1-L inhibits EGFR signaling in lung adenocarcinoma by enhancing EGFR Ubiquitinylation and degradation.
    Chen CY; Jan CI; Lo JF; Yang SC; Chang YL; Pan SH; Wang WL; Hong TM; Yang PC
    Cancer Res; 2013 Jul; 73(13):4009-19. PubMed ID: 23698466
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silencing of lncRNA LOC105376794 promotes migration, invasion, and Gefitinib resistance of lung adenocarcinoma cells with EGFR 19Del mutation by ATF4/CHOP axis and ERK phosphorylation.
    Liu W; Duan Z; Wu Y; Ma R
    Neoplasma; 2024 Jun; 71(3):219-230. PubMed ID: 38958710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation.
    Yamaoka T; Ohmori T; Ohba M; Arata S; Murata Y; Kusumoto S; Ando K; Ishida H; Ohnishi T; Sasaki Y
    Mol Cancer Res; 2017 Jul; 15(7):915-928. PubMed ID: 28289161
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression.
    Lin CC; Huang YK; Cho CF; Lin YS; Lo CC; Kuo TT; Tseng GC; Cheng WC; Chang WC; Hsiao TH; Lai LC; Shih JY; Liu YH; Chao KSC; Hsu JL; Lee PC; Sun X; Hung MC; Sher YP
    Theranostics; 2020; 10(24):10925-10939. PubMed ID: 33042262
    [No Abstract]   [Full Text] [Related]  

  • 66. STAMBP promotes lung adenocarcinoma metastasis by regulating the EGFR/MAPK signaling pathway.
    Xu H; Yang X; Xuan X; Wu D; Zhang J; Xu X; Zhao Y; Ma C; Li D
    Neoplasia; 2021 Jun; 23(6):607-623. PubMed ID: 34102455
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis.
    Lin EP; Huang BT; Lai WY; Tseng YT; Yang SC; Kuo HC; Yang PC
    Cancer Res; 2021 Apr; 81(7):1745-1757. PubMed ID: 33574089
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 69. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.
    Chung BM; Raja SM; Clubb RJ; Tu C; George M; Band V; Band H
    BMC Cell Biol; 2009 Nov; 10():84. PubMed ID: 19948031
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma.
    Makinoshima H; Takita M; Matsumoto S; Yagishita A; Owada S; Esumi H; Tsuchihara K
    J Biol Chem; 2014 Jul; 289(30):20813-23. PubMed ID: 24928511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
    Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
    Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of caveolin-1 is correlated with lung adenocarcinoma proliferation, migration, and invasion.
    Luan TY; Zhu TN; Cui YJ; Zhang G; Song XJ; Gao DM; Zhang YM; Zhao QL; Liu S; Su TY; Zhao RJ
    Med Oncol; 2015 Jul; 32(7):207. PubMed ID: 26094077
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenografts.
    Cui J; Zhang Y; Su D; Li T; Li Y
    Thorac Cancer; 2018 Sep; 9(9):1156-1165. PubMed ID: 30047610
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.
    Ortiz-Zapater E; Lee RW; Owen W; Weitsman G; Fruhwirth G; Dunn RG; Neat MJ; McCaughan F; Parker P; Ng T; Santis G
    PLoS One; 2017; 12(1):e0170798. PubMed ID: 28141869
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
    Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
    Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NF-κB signaling is activated and confers resistance to apoptosis in three-dimensionally cultured EGFR-mutant lung adenocarcinoma cells.
    Sakuma Y; Yamazaki Y; Nakamura Y; Yoshihara M; Matsukuma S; Koizume S; Miyagi Y
    Biochem Biophys Res Commun; 2012 Jul; 423(4):667-71. PubMed ID: 22695117
    [TBL] [Abstract][Full Text] [Related]  

  • 78. PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2.
    Kuo HY; Huang YS; Tseng CH; Chen YC; Chang YW; Shih HM; Wu CW
    Cell Cycle; 2014; 13(19):3132-42. PubMed ID: 25486572
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PAQR3 suppresses the growth of non-small cell lung cancer cells via modulation of EGFR-mediated autophagy.
    Cao Q; You X; Xu L; Wang L; Chen Y
    Autophagy; 2020 Jul; 16(7):1236-1247. PubMed ID: 31448672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Laser capture microdissection and protein microarray analysis of human non-small cell lung cancer: differential epidermal growth factor receptor (EGPR) phosphorylation events associated with mutated EGFR compared with wild type.
    VanMeter AJ; Rodriguez AS; Bowman ED; Jen J; Harris CC; Deng J; Calvert VS; Silvestri A; Fredolini C; Chandhoke V; Petricoin EF; Liotta LA; Espina V
    Mol Cell Proteomics; 2008 Oct; 7(10):1902-24. PubMed ID: 18687633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.